Kuster's Legislation To Increase Transparency Around Drug Pricing Advances Key Subcommittee
May 18, 2023
May 18, 2023
WASHINGTON, May 18 -- Rep. Ann Kuster, D-New Hampshire, issued the following news release on May 17, 2023:
The Energy and Commerce Health Subcommittee advanced two pieces of legislation led by Congresswoman Annie Kuster (NH-02) to increase drug pricing transparency. The PBM Accountability Act would shed light on drug pricing decisions by requiring that pharmacy benefit managers, PBMs, file regular reports about how some drugs are covered, valued, and categorized. The Increasing Tran . . .
The Energy and Commerce Health Subcommittee advanced two pieces of legislation led by Congresswoman Annie Kuster (NH-02) to increase drug pricing transparency. The PBM Accountability Act would shed light on drug pricing decisions by requiring that pharmacy benefit managers, PBMs, file regular reports about how some drugs are covered, valued, and categorized. The Increasing Tran . . .